Le Zhu - Search Results

Year	Number of Results
2004	1
2005	1
2006	2
2007	2
2009	1
2012	2
2013	1
2014	1
2017	2
2018	2
2019	3
2020	7
2021	4
2022	3
2023	11
2024	10

1

Isolation and characterization of exosomes for cancer research.

Zhu L, Sun HT, Wang S, Huang SL, Zheng Y, Wang CQ, Hu BY, Qin W, Zou TT, Fu Y, Shen XT, Zhu WW, Geng Y, Lu L, Jia HL, Qin LX, Dong QZ. Zhu L, et al. J Hematol Oncol. 2020 Nov 10;13(1):152. doi: 10.1186/s13045-020-00987-y. J Hematol Oncol. 2020. PMID: 33168028 Free PMC article. Review.

2

Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3-ABCB1 Signaling in Hepatocellular Carcinoma.

Hu B, Zou T, Qin W, Shen X, Su Y, Li J, Chen Y, Zhang Z, Sun H, Zheng Y, Wang CQ, Wang Z, Li TE, Wang S, Zhu L, Wang X, Fu Y, Ren X, Dong Q, Qin LX. Hu B, et al. Among authors: zhu l. Cancer Res. 2022 Oct 17;82(20):3845-3857. doi: 10.1158/0008-5472.CAN-21-4140. Cancer Res. 2022. PMID: 36066408 Free PMC article.

3

Modulation of cellular metabolism by protein crotonylation regulates pancreatic cancer progression.

Zheng Y, Zhu L, Qin ZY, Guo Y, Wang S, Xue M, Shen KY, Hu BY, Wang XF, Wang CQ, Qin LX, Dong QZ. Zheng Y, et al. Among authors: zhu l. Cell Rep. 2023 Jul 25;42(7):112666. doi: 10.1016/j.celrep.2023.112666. Epub 2023 Jun 21. Cell Rep. 2023. PMID: 37347667 Free article.

4

Single-cell mapping reveals several immune subsets associated with liver metastasis of pancreatic ductal adenocarcinoma.

Zhang Z, Zhu XQ, Yang F, Lai NN, Zhu L, Cole K, Hu BY, Li TE, Zhu Y, Zhang LM, Wang S, Zheng Y, Mao H, Zhao Y, Bruns C, Vago R, Tu B, Wong JWH, Fu DL, Qin LX, Dong QZ. Zhang Z, et al. Among authors: zhu l. Med. 2023 Oct 13;4(10):728-743.e7. doi: 10.1016/j.medj.2023.07.010. Epub 2023 Aug 25. Med. 2023. PMID: 37633269

5

Implications of hydrogen sulfide in colorectal cancer: Mechanistic insights and diagnostic and therapeutic strategies.

Lin H, Yu Y, Zhu L, Lai N, Zhang L, Guo Y, Lin X, Yang D, Ren N, Zhu Z, Dong Q. Lin H, et al. Among authors: zhu l. Redox Biol. 2023 Feb;59:102601. doi: 10.1016/j.redox.2023.102601. Epub 2023 Jan 7. Redox Biol. 2023. PMID: 36630819 Free PMC article. Review.

6

Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis.

Fu Y, Shen K, Wang H, Wang S, Wang X, Zhu L, Zheng Y, Zou T, Ci H, Dong Q, Qin LX. Fu Y, et al. Among authors: zhu l. Signal Transduct Target Ther. 2024 Mar 8;9(1):63. doi: 10.1038/s41392-024-01761-z. Signal Transduct Target Ther. 2024. PMID: 38453934 Free PMC article.

7

Simultaneous deep transcriptome and proteome profiling in a single mouse oocyte.

Jiang YR, Zhu L, Cao LR, Wu Q, Chen JB, Wang Y, Wu J, Zhang TY, Wang ZL, Guan ZY, Xu QQ, Fan QX, Shi SW, Wang HF, Pan JZ, Fu XD, Wang Y, Fang Q. Jiang YR, et al. Among authors: zhu l. Cell Rep. 2023 Nov 28;42(11):113455. doi: 10.1016/j.celrep.2023.113455. Epub 2023 Nov 16. Cell Rep. 2023. PMID: 37976159 Free article.

8

System Analysis Based on Lipid-Metabolism-Related Genes Identifies AGT as a Novel Therapy Target for Gastric Cancer with Neoadjuvant Chemotherapy.

Zhu L, Ma M, Zhang L, Wang S, Guo Y, Ling X, Lin H, Lai N, Lin S, Du L, Dong Q. Zhu L, et al. Pharmaceutics. 2023 Mar 2;15(3):810. doi: 10.3390/pharmaceutics15030810. Pharmaceutics. 2023. PMID: 36986671 Free PMC article.

9

Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma.

Wang S, Zhu L, Li T, Lin X, Zheng Y, Xu D, Guo Y, Zhang Z, Fu Y, Wang H, Wang X, Zou T, Shen X, Zhang L, Lai N, Lu L, Qin L, Dong Q. Wang S, et al. Among authors: zhu l. Cell Rep Med. 2024 Feb 20;5(2):101415. doi: 10.1016/j.xcrm.2024.101415. Cell Rep Med. 2024. PMID: 38382467 Free PMC article.

10

Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma.

Shen XT, Xie SZ, Zheng X, Zou TT, Hu BY, Xu J, Liu L, Xu YF, Wang XF, Wang H, Wang S, Zhu L, Yu KK, Zhu WW, Lu L, Zhang JB, Chen JH, Dong QZ, Yang LY, Qin LX. Shen XT, et al. Among authors: zhu l. Exp Hematol Oncol. 2024 Feb 22;13(1):20. doi: 10.1186/s40164-024-00476-9. Exp Hematol Oncol. 2024. PMID: 38388466 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

47 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year